Phospho-p27 KIP 1 (Ser10) Antibody

About the Target

CDKN1B is a target of interest in many antibody-based workflows. P27Kip1 is a cyclin-dependent kinase inhibitor (CKI) that regulates cell cycle progression during the G1 phase by interacting with and inhibiting cyclin-dependent kinase (CDK)/cyclin complexes. Regulation of p27 expression and function involves transcriptional and translational mechanisms, as well as degradation by the 26S proteasome and miRNA. Depending on the literature source, CDKN1B may also be discussed as Phospho-p27 KIP 1 (Ser10) and Phospho p27 KIP 1 (Ser 10).

Reported cellular context includes nucleus, cytoplasm, and endosome, which can matter when signal is compared across treatments or changing cell states. Following CDKN1B across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CDKN1B is commonly interpreted in the context of cell cycle and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans nucleus, cytoplasm, and endosome, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between nucleus, cytoplasm, and endosome across matched conditions
• cell-cycle linked differences in abundance, timing, or compartmental enrichment
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• differences between total target abundance and site-specific regulation when modified forms are compared

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CDKN1B. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CDKN1B reflect biology rather than handling. When interpreting CDKN1B, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CDKN1B trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.